1-8 of 8
Martin Wolfsegger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Gerald Hoebarth, Alexandra Kopic, Martin Wolfsegger, Cstat (RSS), Alexander Bauer, Peter L. Turecek, PhD, Peter Leidenmuehler, Karima Benamara, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 2590.
https://doi.org/10.1182/blood.V128.22.2590.2590
Published: 2016
Journal Articles

Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

Veronika Ehrlich, Peter Leidenmuehler, Barbara Dietrich, Gerald Hoebarth, Tanja Ruthsatz, Peter L. Turecek, PhD, Martin Wolfsegger, Cstat (RSS), Alfred Weber, Herbert Gritsch, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 4977.
https://doi.org/10.1182/blood.V128.22.4977.4977
Published: 2016
Journal Articles

Modelling FVIII Levels for Prediction of Zero Spontaneous-Joint Bleeding in a Cohort of Severe Hemophilia a Subjects with Target Joints Initiated on Tertiary Prophylaxis

Kathelijn Fischer, MD PhD MSc, Pratima Chowdary, FRCPath, MRCPath, MRCP, MD, Peter Collins, MD, Amy Cotterill, PhD, Barbara Konkle, MD, Victor S. Blanchette, FRCP, FRCPC, Steven W. Pipe, MD, Martin Wolfsegger, Cstat (RSS), Werner Engl, PhD Cstat, Jimena V Goldstine, PhD, Leonard A. Valentino, MD FAAP, Gerald Spotts, PhD
Journal: Blood
Blood (2016) 128 (22): 2576.
https://doi.org/10.1182/blood.V128.22.2576.2576
Published: 2016
Journal Articles

Pharmacokinetics of BAX 826, a Polysialylated Full-Length rFVIII, in Hemophilia a Mice, Rats, and Cynomolgus Monkeys

Alexandra Schiviz, DVM, Gerald Hoebarth, Martin Wolfsegger, Paolo Rossato, Alfred Weber, Herbert Gritsch, Hanspeter Rottensteiner, PhD, Peter L. Turecek, PhD, Friedrich Scheiflinger, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS
Journal: Blood
Blood (2015) 126 (23): 1073.
https://doi.org/10.1182/blood.V126.23.1073.1073
Published: 2015
Journal Articles

Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys

Barbara Dietrich, DVM, Margit Spatzenegger, PhD, Reinhard Stidl, PhD, Martin Wolfsegger, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4345.
https://doi.org/10.1182/blood.V118.21.4345.4345
Published: 2011
Journal Articles

Pharmacokinetics of Baxter’s Longer Acting rFVIII (BAX 855) in Factor VIII Ko Mice, Rats and Cynomolgus Monkeys

Gerald Hoebarth, DVM, Susan Kubik, BSc, Martin Wolfsegger, PhD, John-Philip Lawo, Alfred Weber, PhD, Herbert Gritsch, Werner Hoellriegl, Alexandra Schiviz, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter L Turecek, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4346.
https://doi.org/10.1182/blood.V118.21.4346.4346
Published: 2011
Journal Articles

Preclinical Safety of Baxter's Recombinant Factor IX

Barbara Dietrich, PhD, Susan Kubik, PhD, Wilfried Auer, PhD, Kuno Wuersch, PhD, Birgit Reipert, PhD, Frank Horling, PhD, Martin Wolfsegger, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2010) 116 (21): 4654.
https://doi.org/10.1182/blood.V116.21.4654.4654
Published: 2010
Journal Articles

Single Dose Pharmacokinetics of a Recombinant FVIIa In Factor VIII KO Mice, Rats, and Cynomolgus Monkeys

Gerald Hoebarth, PhD, Susan Kubik, PhD, Martin Wolfsegger, PhD, John-Philip Lawo, PhD, Alfred Weber, PhD, Herbert Gritsch, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2010) 116 (21): 4655.
https://doi.org/10.1182/blood.V116.21.4655.4655
Published: 2010